Incidence and prevalence of idiopathic pulmonary fibrosis.

By G. Raghu, D. Weycker, J. Edelsberg, W. Bradford, G. Oster. American Journal of Respiratory and Critical Care Medicine, 2006

1,236 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline (2018, background): “The incidence of IPF increases with older age, with presentation typically consisting of insidious onset of dyspnea in the sixth and seventh decades (8, 9).”
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review (2015, background): “similarly to their previous study (2), and reported lower incidence rates of 31.”
Ageing and the epidemiology of multimorbidity (2014, background): “IPF represents about 20% of the burden of ILDs, so the total burden of ILD may be much higher [20].”
Clinical course and prediction of survival in idiopathic pulmonary fibrosis. (2011, background): “Older age is a clinical feature of IPF with a median age of 66 years at the time of diagnosis (1, 47).”
Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance (2014, background): “Fibrotic disorders account for increasing morbidity and mortality worldwide, and aging is a known risk factor (8, 9).”